Connection

Robert Grubb to 5-alpha Reductase Inhibitors

Back to Details
This is a "connection" page, showing publications Robert Grubb has written about 5-alpha Reductase Inhibitors.
Robert Grubb
Connection Strength
0.129
5-alpha Reductase Inhibitors
  1. The REDUCE Follow-Up Study: low rate of new prostate cancer diagnoses observed during a 2-year, observational, followup study of men who participated in the REDUCE trial. J Urol. 2013 Mar; 189(3):871-7.
    View in: PubMed
    Score: 0.104
  2. Projecting prostate cancer mortality in the PCPT and REDUCE chemoprevention trials. Cancer. 2013 Feb 01; 119(3):593-601.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.